Highlights and Quick Summary
- Common Equity (Total) for the quarter ending June 30, 2023 was $5.5 Million (a -64.15% decrease compared to previous quarter)
- Year-over-year quarterly Common Equity (Total) decreased by -84.22%
- Annual Common Equity (Total) for 2022 was $25 Million (a -56.76% decrease from previous year)
- Annual Common Equity (Total) for 2021 was $57.8 Million (a 44.04% increase from previous year)
- Annual Common Equity (Total) for 2020 was $40.1 Million (a 75.48% increase from previous year)
Visit stockrow.com/DRRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Common Equity (Total) of DURECT Corporation
Most recent Common Equity (Total)of DRRX including historical data for past 10 years.Interactive Chart of Common Equity (Total) of DURECT Corporation
DURECT Corporation Common Equity (Total) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $5.5 | $15.34 | – | – | – |
| 2022 | $24.99 | $34.85 | $36.7 | $47.61 | $24.99 |
| 2021 | $57.78 | $64.03 | $73.46 | $81.72 | $57.78 |
| 2020 | $40.12 | $34.7 | $36.34 | $14.07 | $40.12 |
| 2019 | $22.86 | $22.01 | $22.89 | $14.36 | $22.86 |
| 2018 | $20.0 | $26.09 | $28.27 | $30.4 | $20.0 |
| 2017 | $21.49 | $10.04 | $-1.84 | $3.25 | $21.49 |
| 2016 | $8.34 | $12.94 | $19.16 | $10.23 | $8.34 |
| 2015 | $14.88 | $17.21 | $22.86 | $15.48 | $14.88 |
| 2014 | $18.52 | $23.58 | $25.07 | $29.67 | $18.52 |
| 2013 | $30.72 | $24.17 | $29.32 | $33.53 | $30.72 |
| 2012 | $36.33 | $29.06 | – | – | $36.33 |
Business Profile of DURECT Corporation
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic